Systemic Thrombolysis and Anticoagulation for Early Post-Fontan Thrombosis: A Five-Patient Case Series
World Journal for Pediatric and Congenital Heart Surgery · 2026
DOI: 10.1177/21501351261428080 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal for Pediatric and Congenital Heart Surgery, 2026. Verfasst von Sanketh Edem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Anticoagulants, Fibrinolytic Agents, Fontan Procedure, Heart Defects, Congenital. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Background
Thrombosis of the Fontan circuit or inferior vena cava (IVC) is an uncommon but serious early postoperative complication that can result in conduit obstruction and hemodynamic compromise. Early detection and timely intervention are critical to prevent Fontan pathway failure.
Methods
We retrospectively reviewed 5 consecutive patients who developed imaging-confirmed venous thrombosis within the first postoperative week following Fontan completion surgery. The cohort included 1 detailed index case and 4 additional cases managed at the same institution. All patients presented with persistent, culture-negative fever between postoperative days 3 and 5. Thrombus location, treatment strategy, and outcomes were analyzed. Systemic thrombolysis was performed using recombinant tissue plasminogen activator (tPA; alteplase; 0.1 mg kg −1 bolus followed by 0.5 mg kg −1 h −1 for 6 h, maximum 50 mg) under continuous unfractionated heparin infusion.
Results
Thrombus sites included the IVC ( n = 3), iliac veins ( n = 1), and extracardiac conduit ( n = 1). Three patients—including the index case—received systemic tPA with complete radiological resolution and no bleeding or neurological complications. Two patients were successfully managed with 48 h of heparin infusion alone. Fever subsided within 48 h of therapy, and all patients achieved complete venous recanalization within 2 to 3 days. No patient experienced rethrombosis or major bleeding during 3 to 6 months of follow-up.
Conclusion
Persistent postoperative fever in a Fontan patient should prompt evaluation for thrombus formation, particularly when infection is excluded. Both short-course systemic thrombolysis and therapeutic heparinization are safe and effective first-line strategies for early post-Fontan thrombosis when applied under strict multimodal monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic and Vascular Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Cardiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Sanketh Edem, Naveen Deep Kaur
Zitieren
APA
Edem, S., Reddy, L., Mishra, A. K., Barwad, P., Kaur, N. D., & Choudhury, R. (2026). Systemic Thrombolysis and Anticoagulation for Early Post-Fontan Thrombosis: A Five-Patient Case Series. World Journal for Pediatric and Congenital Heart Surgery. https://doi.org/10.1177/21501351261428080
Vancouver
Edem S, Reddy L, Mishra AK, Barwad P, Kaur ND, Choudhury R. Systemic Thrombolysis and Anticoagulation for Early Post-Fontan Thrombosis: A Five-Patient Case Series. World Journal for Pediatric and Congenital Heart Surgery. 2026. doi:10.1177/21501351261428080
BibTeX
@article{Edem2026,
author = {Edem, Sanketh and Reddy, Lasya and Mishra, Anand Kumar and Barwad, Parag and Kaur, Naveen Deep and Choudhury, Raghuveer},
title = {Systemic Thrombolysis and Anticoagulation for Early Post-Fontan Thrombosis: A Five-Patient Case Series},
journal = {World Journal for Pediatric and Congenital Heart Surgery},
year = {2026},
doi = {10.1177/21501351261428080}
}
EUVIMED